advertisement

---

European Journal of Pharmaceutics and Biopharmaceutics 11

Showing records 1 to 11 | Display all abstracts in European Journal of Pharmaceutics and Biopharmaceutics

60575 Nanotherapies for the treatment of ocular diseases
Reimondez-Troitiño S
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293

---

60165 Treatment of ocular disorders by gene therapy
Solinís MÁ
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 331-342

---

60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Chen YS
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193

---

60575 Nanotherapies for the treatment of ocular diseases
Csaba N
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293

---

60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Green CR
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193

---

60165 Treatment of ocular disorders by gene therapy
Del Pozo-Rodríguez A
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 331-342

---

60575 Nanotherapies for the treatment of ocular diseases
Alonso MJ
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293

---

60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Danesh-Meyer HV
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193

---

60165 Treatment of ocular disorders by gene therapy
Apaolaza PS; Rodríguez-Gascón A
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 331-342

---

60457 Neuroprotection in the treatment of glaucoma - A focus on connexin43 gap junction channel blockers
Rupenthal ID
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 182-193

---

60575 Nanotherapies for the treatment of ocular diseases
de la Fuente M
European Journal of Pharmaceutics and Biopharmaceutics 2015; 95: 279-293

---